NZX/ASX Announcement
14 December 2023
TruScreen Wins Top Prize in Poland’s international Mother and Child Institute (MCI) Start Up Challenge
Highlights of the prizes:
• Main sponsor’s prize: MCI and OVHcloud grand prize: one-year support for implementation of technology in Poland and 100,000 euros of icloud storage
• Sponsor TIKA company; prize: free access to the online course "Successful Market Entry - the USA."
• GE HealthCare; prize: mentoring support (12h).
TruScreen Group Limited (NZX/ASX:TRU) is pleased to announce winning the Polish Mother and Child Institute (MCI) Start Up Challenge as one of top 2 winners among 51 international submissions of advanced, innovative technologies, focused on artificial intelligence and data acquisition in healthcare.
This 7-month long competition, was sponsored by 17 international organisations, including Medical Research Agency and Poland’s Ministry of Health, IQvia, GE Healthcare, Astra Zeneca and European Union, among others. This significant award recognition will accelerate TruScreen technology implementation in a leading public hospital network in Poland. In their acknowledgement, the Selection Committee, consisting of MCI, and several top Polish healthcare organisations recognised the value of TruScreen, accelerating cervical cancer screening at lower public healthcare costs and more patient-focused, innovative approach.
The prizes will enable TruScreen to accelerate its data acquisition and enable highly regarded mentoring access from one of the global healthcare innovators, GE Healthcare.
CEO, Dr Beata Edling commented:
“Our sincere thanks to the MCSC hospitals, GE Healthcare, Tika, OVHcloud, and organisers of the international competition, for enabling acceleration of the implementation of TruScreen in Poland and Eastern Europe. We thank you for recognising TruScreen technology as an excellent screening method for cervical cancer, fit for 21st century healthcare. TruScreen is world-class technology made simple enabling women access to a painless, fast, and very reliable cervical screening. We are delighted with the recognition and look forward to collaborating on reducing cervical cancer in Poland.”
This announcement has been approved by the Board.
Ends
For more information, visit www.truscreen.com or contact:
Dr Beata Edling
Chief Executive Officer
[email protected]
Guy Robertson
Chief Financial Officer
[email protected]
Dips for Fisher and Paykel Healthcare and Fletcher Building drive market down.
The two resignations follow chief executive Greg Smith's departure.
The company’s rental income rose 1.64%.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details